Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.
This report contains market size and forecasts of Metabolic Disease Therapeutics in Global, including the following market information:
Global Metabolic Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Metabolic Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glycogen Metabolism Disease Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metabolic Disease Therapeutics include Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metabolic Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metabolic Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Metabolic Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other
Global Metabolic Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Metabolic Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Global Metabolic Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Metabolic Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabolic Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Metabolic Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma